advisorsecurities master

FENCFennec Pharmaceuticals Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
15272
Ticker
FENC
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2002-01-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
FENC

Detail

Enriched 2026-08-14 20:47

Market cap
$414,452,220
Shares outstanding (class)
35,058,266
Shares outstanding (weighted)
35,034,000
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
35
Location
RESEARCH TRIANGLE PARK, NC
Description

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data